Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

NCT01776060

CompletedN/A

Sponsor: Duke University

Conditions: Primary Progressive Multiple Sclerosis

Interventions: generation of 'omic markers of disease progression

Countries: United States

The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow up questionnaire and blood/urine collection for a period of 5 years.

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Enrolled in the MURDOCK Study Horizon 1.5 (Pro00011196)
* Enrolled in the Multiple Sclerosis Cohort (Pro00023791)
* Diagnosed with Primary Progressive Multiple Sclerosis
* At least 18 years of age

Exclusion Criteria:

* Participants not willing to participate or sign informed consent
Locations (3)
  • Concord, North Carolina, United States
  • Durham, North Carolina, United States
  • Raleigh, North Carolina, United States